Worth reading
47Recurring
Scored from 4 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
1622100
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Issuance of performance-based mid-term and long-term share options (stock options)
発行・処分する株式数
Series 15 (A) performance-based mid-term share options 698,000 shares (6,980 share options, 100 shares per option) / Series 15 (B) performance-based long-term share options 924,100 shares (9,241 share options, 100 shares per option)
Intended allottee
Category Directors / Number of Employees 2 / Series 15 (A) 3,944 options / Series 15 (B) 7,609 options, Category Executive officers / Number of Employees 1 / Series 15 (A) 816 options / Series 15 (B) 1,632 options, Category Senior employees at department-head level / Number of Employees 3 / Series 15 (A) 2,220 stock acquisition rights / Series 15 (B) Not disclosed
The payment amount for the stock acquisition rights will be their fair value calculated using the Black-Scholes model on the allotment date. The exercise price will be ¥1 per share.
Amount of funds to be raised
The total payment amount based on the exercise price will be ¥698,000 for Series 15 (A) and ¥924,100 for Series 15 (B). The estimated net proceeds are Not disclosed.
Total Stock-Based Compensation
The Company will pay monetary compensation equivalent to the total payment amount for the share options and offset the compensation claims against the payment obligation. The amount is Not disclosed.
発行済株式総数
The number of issued shares may increase by up to 1,622,100 shares upon exercise of the share options.
Terms of the stock acquisition rights
Exercise price
The initial exercise price will be ¥1 per share. The adjustment provisions and adjustment floor are Not disclosed.
Exercise period
Series 15 (A) From 8 August 2029 to 7 August 2032 / Series 15 (B) From 8 August 2026 to 7 August 2056
Number of Stock Acquisition Rights
Total number issued Series 15 (A) 6,980 options / Series 15 (B) 9,241 options / Number of unexercised units Not disclosed
Reason for acquisition without consideration
If a merger in which the Company is the disappearing company, or a share exchange or share transfer under which the Company becomes a wholly owned subsidiary, is approved at a shareholders meeting, or if the holder of the share options or the holder's statutory heir becomes unable to exercise all or part of the options under the exercise conditions.
Categories and Number of Persons Covered
Category Directors / Number of Employees 2 / Number of Series 15 (A) options allotted 3,944 options / Number of Series 15 (B) options allotted 7,609 options, Category Executive officers / Number of Employees 1 / Number of Series 15 (A) options allotted 816 options / Number of Series 15 (B) options allotted 1,632 options, Category Senior employees at department-head level / Number of Employees 3 / Number of Series 15 (A) options allotted 2,220 stock acquisition rights / Number of Series 15 (B) options allotted Not disclosed
Intended allottee's holding policy
The transfer of the stock acquisition rights requires approval by resolution of the Company's Board of Directors
Payment date
7 August 2026 (the allotment date for the share options)
Basis for determining the amount to be paid
The payment amount for the stock acquisition rights will be their fair value calculated using the Black-Scholes model on the allotment date. The exercise price will be ¥1 per share.
Procedures under the Corporate Code of Conduct
Approved by resolution of the Board of Directors pursuant to Articles 236, 238 and 240 of the Companies Act.
Most recent equity financing
Timing At the time of the previous issuance (timing: Not disclosed) / Type Series 14 (A) performance-based mid-term share options and Series 14 (B) performance-based long-term share options / Amount Not disclosed
| Item | Details |
|---|---|
| Type of issuance or disposal | Issuance of performance-based mid-term and long-term share options (stock options) |
| Number of shares to be issued or disposed of | Series 15 (A) performance-based mid-term share options 698,000 shares (6,980 share options, 100 shares per option) / Series 15 (B) performance-based long-term share options 924,100 shares (9,241 share options, 100 shares per option) |
| Issue price and disposal price | The payment amount for the stock acquisition rights will be their fair value calculated using the Black-Scholes model on the allotment date. The exercise price will be ¥1 per share. |
| Amount of funds to be raised | The total payment amount based on the exercise price will be ¥698,000 for Series 15 (A) and ¥924,100 for Series 15 (B). The estimated net proceeds are Not disclosed. |
| Payment date | 7 August 2026 (the allotment date for the share options) |
| Intended allottee | Category Directors / Number of Employees 2 / Series 15 (A) 3,944 options / Series 15 (B) 7,609 options, Category Executive officers / Number of Employees 1 / Series 15 (A) 816 options / Series 15 (B) 1,632 options, Category Senior employees at department-head level / Number of Employees 3 / Series 15 (A) 2,220 stock acquisition rights / Series 15 (B) Not disclosed |
| Intended allottee's holding policy | The transfer of the stock acquisition rights requires approval by resolution of the Company's Board of Directors |
| Total number of issued shares | The number of issued shares may increase by up to 1,622,100 shares upon exercise of the share options. |
| Basis for determining the amount to be paid | The payment amount for the stock acquisition rights will be their fair value calculated using the Black-Scholes model on the allotment date. The exercise price will be ¥1 per share. |
| Exercise price | The initial exercise price will be ¥1 per share. The adjustment provisions and adjustment floor are Not disclosed. |
| Exercise period | Series 15 (A) From 8 August 2029 to 7 August 2032 / Series 15 (B) From 8 August 2026 to 7 August 2056 |
| Number of Stock Acquisition Rights | Total number issued Series 15 (A) 6,980 options / Series 15 (B) 9,241 options / Number of unexercised units Not disclosed |
| Reason for acquisition without consideration | If a merger in which the Company is the disappearing company, or a share exchange or share transfer under which the Company becomes a wholly owned subsidiary, is approved at a shareholders meeting, or if the holder of the share options or the holder's statutory heir becomes unable to exercise all or part of the options under the exercise conditions. |
| Categories and Number of Persons Covered | Category Directors / Number of Employees 2 / Number of Series 15 (A) options allotted 3,944 options / Number of Series 15 (B) options allotted 7,609 options, Category Executive officers / Number of Employees 1 / Number of Series 15 (A) options allotted 816 options / Number of Series 15 (B) options allotted 1,632 options, Category Senior employees at department-head level / Number of Employees 3 / Number of Series 15 (A) options allotted 2,220 stock acquisition rights / Number of Series 15 (B) options allotted Not disclosed |
| Total Stock-Based Compensation | The Company will pay monetary compensation equivalent to the total payment amount for the share options and offset the compensation claims against the payment obligation. The amount is Not disclosed. |
| Procedures under the Corporate Code of Conduct | Approved by resolution of the Board of Directors pursuant to Articles 236, 238 and 240 of the Companies Act. |
| Most recent equity financing | Timing At the time of the previous issuance (timing: Not disclosed) / Type Series 14 (A) performance-based mid-term share options and Series 14 (B) performance-based long-term share options / Amount Not disclosed |
Items this document does not state (11)
Total issue valueEstimated issuance expensesSpecific use of fundsDilution RateTransfer restriction periodConditions for lifting transfer restrictionsUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To provide incentives for achieving the mid-term management plan announced on 7 August 2025, reflect the management efforts of the eligible persons in their mid- to long-term compensation, and enhance their motivation and morale to increase the share price and improve business performance through sound management.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.